NCT06066060

A DDI Study of JMKX000623 and Metformin Hydrochloride

Phase I Study to Evaluate the Drug-Drug Interaction (DDI) Between JMKX000623 Tablets and Metformin Hydrochloride Tablets in Healthy Chinese Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 24 (actual)
• Sponsor: Jemincare · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Not accepted

Summary

A phase 1, single center, 1 sequence, 3 period, open label, multiple doses study to evaluate the drug-drug interaction of JMKX000623 tablet and metformin.

Detailed description

The drug-drug interaction study is meant to evaluate the pharmacokinetics and safety of JMKX000623 tablet combined metformin in healthy volunteers

Conditions

• Healthy
• Drug-Drug Interaction

Interventions

Type	Name	Description
DRUG	JMKX000623	JMKX000623, administered orally ;
DRUG	Metformin	Metformin,administered orally

Timeline

• Start date: 2023-09-17
• Primary completion: 2023-11-06
• Completion: 2023-11-06
• First posted: 2023-10-04
• Last updated: 2024-04-25

Locations

1 site across 1 country: China